342
Views
35
CrossRef citations to date
0
Altmetric
Research Article

Mannosylated liposomes improve therapeutic effects of paclitaxel in colon cancer models

, , , , , , , , & show all
Pages 513-521 | Received 25 Feb 2017, Accepted 05 Jun 2017, Published online: 26 Jul 2017

References

  • Abbas Z. 2011. Development of tools to target antigen through mannose receptor. Nottingham: University of Nottingham.
  • Alvarez Y, Valera I, Municio C, Hugo E, Padron F, Blanco L, Rodriguez M, Fernandez N, Crespo SC. Eicosanoids in the innate immune response: TLR and non-TLR routes. Mediat Inflamm, 2010;2010(1):111–16.
  • Choi IK, Hyun JJ, Kim SY, Jung SW, Koo JS, Kim JH, Yim HJ, Lee SW. Influence of socioeconomic status on survival and clinical outcomes in patients with advanced gastric cancer after chemotherapy. Oncol Res Treat, 2014;37(6):310–14.
  • Estanqueiro M, Amaral MH, Conceição J, Sousa Lobo JM. Nanotechnological carriers for cancer chemotherapy: The state of the art. Colloids Surf B Biointerfaces, 2015;126:631.
  • Gao T, Zhang L, Zhu Y, Song X, Feng Q, Lei Q, Shi S, Deng H, Xiong M, You X, et al. ZLD1122, a novel EZH2 and EZH1 small molecular inhibitor, blocks H3K27 methylation and diffuse large B cell lymphoma cell growth. RSC Adv, 2016;6(34):28512–21.
  • Guan P, Lu Y, Qi J, Niu M, Lian R, Wu W. Solidification of liposomes by freeze-drying: The importance of incorporating gelatin as interior support on enhanced physical stability. Int J Pharm, 2015;478(2):655–64.
  • Ishiguro M, Watanabe T, Kotake K, Sughihara K. Japanese Society for Cancer of the Colon and Rectum Guidelines 2010 for the treatment of colorectal cancer: Comparison with western guidelines. Colorectal Cancer, 2016; 2(2):179–90.
  • Lei Q, Zhang L, Xia Y, Ye T, Yang F, Zhu Y, Song X, Wang N, Xu Y, Liu X, Yu L. A novel benzothiazole derivative SKLB826 inhibits human hepatocellular carcinoma growth via inducing G2/M phase arrest and apoptosis. RSC Adv, 2015;5(52):41341–51.
  • Li X, Qin F, Yang L, Mo L, Li L, Hou L. Sulfatide-containing lipid perfluorooctylbromide nanoparticles as paclitaxel vehicles targeting breast carcinoma. Int J Nanomed, 2014;9(1):3971–85.
  • Li X, Zheng X, Wei X, Guo G, Gou M, Gong C, Wang X, Dai M, Chen L, Wei Y, Qian Z. A novel composite drug delivery system: Honokiol nanoparticles in thermosensitive hydrogel based on chitosan. J Nanosci Nanotechnol, 2009;9(8):4586–92.
  • Liu Y, Ran R, Chen J, Kuang Q, Tang J, Mei L, Zhang Q, Gao H, Zhang Z, He Q. Paclitaxel loaded liposomes decorated with a multifunctional tandem peptide for glioma targeting. Biomaterials, 2014;35(17):4835–47.
  • Mao SJ, Bi YQ, Jin H, Wei DP, He R, Hou SX. Preparation, characterization and uptake by primary cultured rat hepatocytes of liposomes surface-modified with glycyrrhetinic acid. Pharmazie, 2007;62(8):614–19.
  • Martinez-Pomares L. The mannose receptor. J Leukocyte Biol, 2012;92(6):1177–86.
  • Martinez-Pomares L, Reid DM, Brown GD, Taylor PR, Stillion RJ, Linehan SA, Zamze S, Gordon S, Wong SY. Analysis of mannose receptor regulation by IL-4, IL-10, and proteolytic processing using novel monoclonal antibodies. J Leukocyte Biol, 2003;73(5):604.
  • Meer S, Galpin JS, Altini M, Coleman H, Ali H. Proliferating cell nuclear antigen and Ki67 immunoreactivity in ameloblastomas. Oral Surg Oral Med Oral Pathol Oral Radiol Endodontol, 2003;95(2):213–21.
  • Milczarek M, Filippsurska B, Kutner A, Wietrzyk J. Vitamin D analogs combined with 5-fluorouracil in human HT-29 colon cancer treatment. Oncol Rep, 2014;32(2):491–504.
  • Nguyen H, Katavic P, Bashah NAH, Ferro V. Synthesis of mannose–cholesterol conjugates for targeted liposomal drug delivery. Chemistryselect, 2016;1(1):31–5.
  • Song CK, Balakrishnan P, Shim CK, Chung SJ, Kim DD. Enhanced in vitro cellular uptake of P-gp substrate by poloxamer-modified liposomes (PMLs) in MDR cancer cells. J Microencapsul, 2011;28(6):575–81.
  • Stein M, Keshav S, Harris N, Gordon S. Interleukin 4 potently enhances murine macrophage mannose receptor activity: A marker of alternative immunologic macrophage activation. J Exp Med, 1992;176(1):287–92.
  • Tahover E, Patil YP, Gabizon AA. Emerging delivery systems to reduce doxorubicin cardiotoxicity and improve therapeutic index: Focus on liposomes. Anti-Cancer Drugs, 2014;26(3):241–58.
  • Wang C. Characterization, pharmacokinetics and disposition of novel nanoscale preparations of paclitaxel. Int J Pharm, 2011;414(1–2):251–9.
  • Zhang B, Wang J, Gao J, Guo Y, Chen X, Wang B, Gao J, Rao Z, Chen Z. Alternatively activated RAW264.7 macrophages enhance tumor lymphangiogenesis in mouse lung adenocarcinoma. J Cell Biochem, 2009;107(1):134.
  • Zhi YH, Xi Z, Xiao HW, Xiang RS, Gu H, Wen FW, Shui Y, Sheng JM, Yu QW. Development of glycyrrhetinic acid-modified stealth cationic liposomes for gene delivery. Int J Pharm, 2010;397(1–2):147–54.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.